Aaron Koenig, MD

Therapeutic focus

• Major Depressive Disorder

Recruiting now (1)

All trials (2)

Compounds studied

• Zelquistinel (GATE-251)

Trial sites (33)

• Colorado Springs, Colorado, United States
• Savannah, Georgia, United States
• DeSoto, Texas, United States
• Jacksonville, Florida, United States
• Denver, Colorado, United States
• Huntsville, Alabama, United States
• Orlando, Florida, United States
• Birmingham, Alabama, United States
• Irvine, California, United States
• Independence, Ohio, United States
• Wichita Falls, Texas, United States
• Russells Mills, Massachusetts, United States
• Margate, Florida, United States
• Farmington, Connecticut, United States
• Los Angeles, California, United States
• Walnut Creek, California, United States
• Miami, Florida, United States
• Wichita, Kansas, United States
• Austin, Texas, United States
• Orem, Utah, United States
• Allentown, Pennsylvania, United States
• Las Vegas, Nevada, United States
• Cedarhurst, New York, United States
• Louisville, Kentucky, United States
• San Antonio, Texas, United States
• Boston, Massachusetts, United States
• Upland, California, United States
• Memphis, Tennessee, United States
• Elgin, Illinois, United States
• Houston, Texas, United States
• Bellevue, Washington, United States
• Oklahoma City, Oklahoma, United States
• Encino, California, United States